Loading ...

Treatment With hOKT3gamma1(Ala-Ala) in T1DM

(

Herold / NDB01

)

ITN Protocol #:

ITN007AI

Branded Name:

Herold / NDB01

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Terminated

Summary:

Phase II Multiple Dose Treatment of Type 1 Diabetes Mellitus With hOKT3gamma1(Ala-Ala)

Clinical Operations Manager

ITN Biologist

NIAID Project Manager

Study Personnel:

Protocol Chair

Kevan Herold, MDkevan.herold@yale.edu

Work: 

203-785-6507

Protocol Chair

Carol Soppecsoppe@immunetolerance.org

Work: 

415-353-4879

Protocol Chair

Kristina Harris, PhD

Work: 

Protocol Chair

Peggy Fitzgibbonpeggy.fitzgibbon@nih.gov

Work: 

240-627-3505